Dr. Martens Statistics
Total Valuation
Dr. Martens has a market cap or net worth of 900.11 million. The enterprise value is 1.31 billion.
| Market Cap | 900.11M |
| Enterprise Value | 1.31B |
Important Dates
The last earnings date was Friday, January 23, 2026.
| Earnings Date | Jan 23, 2026 |
| Ex-Dividend Date | Aug 29, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +4.49% |
| Shares Change (QoQ) | -0.27% |
| Owned by Insiders (%) | 1.01% |
| Owned by Institutions (%) | 51.63% |
| Float | 520.16M |
Valuation Ratios
The trailing PE ratio is 43.87 and the forward PE ratio is 14.56.
| PE Ratio | 43.87 |
| Forward PE | 14.56 |
| PS Ratio | 0.86 |
| PB Ratio | 2.04 |
| P/TBV Ratio | 11.96 |
| P/FCF Ratio | 4.62 |
| P/OCF Ratio | 4.36 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.34, with an EV/FCF ratio of 6.73.
| EV / Earnings | 63.91 |
| EV / Sales | 1.22 |
| EV / EBITDA | 7.34 |
| EV / EBIT | 14.39 |
| EV / FCF | 6.73 |
Financial Position
The company has a current ratio of 2.18, with a Debt / Equity ratio of 1.21.
| Current Ratio | 2.18 |
| Quick Ratio | 1.08 |
| Debt / Equity | 1.21 |
| Debt / EBITDA | 3.03 |
| Debt / FCF | 2.73 |
| Interest Coverage | 2.30 |
Financial Efficiency
Return on equity (ROE) is 4.61% and return on invested capital (ROIC) is 6.12%.
| Return on Equity (ROE) | 4.61% |
| Return on Assets (ROA) | 4.64% |
| Return on Invested Capital (ROIC) | 6.12% |
| Return on Capital Employed (ROCE) | 9.77% |
| Weighted Average Cost of Capital (WACC) | 4.84% |
| Revenue Per Employee | 284,518 |
| Profits Per Employee | 5,545 |
| Employee Count | 3,700 |
| Asset Turnover | 0.87 |
| Inventory Turnover | 1.22 |
Taxes
In the past 12 months, Dr. Martens has paid 15.02 million in taxes.
| Income Tax | 15.02M |
| Effective Tax Rate | 42.26% |
Stock Price Statistics
The stock price has increased by +11.43% in the last 52 weeks. The beta is 0.17, so Dr. Martens's price volatility has been lower than the market average.
| Beta (5Y) | 0.17 |
| 52-Week Price Change | +11.43% |
| 50-Day Moving Average | 2.06 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 48.29 |
| Average Volume (20 Days) | 4,751 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dr. Martens had revenue of 1.05 billion and earned 20.52 million in profits. Earnings per share was 0.02.
| Revenue | 1.05B |
| Gross Profit | 689.70M |
| Operating Income | 89.58M |
| Pretax Income | 35.54M |
| Net Income | 20.52M |
| EBITDA | 108.49M |
| EBIT | 89.58M |
| Earnings Per Share (EPS) | 0.02 |
Balance Sheet
The company has 128.34 million in cash and 532.53 million in debt, with a net cash position of -404.19 million.
| Cash & Cash Equivalents | 128.34M |
| Total Debt | 532.53M |
| Net Cash | -404.19M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 441.34M |
| Book Value Per Share | 0.46 |
| Working Capital | 288.06M |
Cash Flow
In the last 12 months, operating cash flow was 206.25 million and capital expenditures -11.26 million, giving a free cash flow of 194.99 million.
| Operating Cash Flow | 206.25M |
| Capital Expenditures | -11.26M |
| Free Cash Flow | 194.99M |
| FCF Per Share | n/a |
Margins
Gross margin is 65.52%, with operating and profit margins of 8.51% and 1.95%.
| Gross Margin | 65.52% |
| Operating Margin | 8.51% |
| Pretax Margin | 3.38% |
| Profit Margin | 1.95% |
| EBITDA Margin | 10.31% |
| EBIT Margin | 8.51% |
| FCF Margin | 18.52% |
Dividends & Yields
This stock pays an annual dividend of 0.06, which amounts to a dividend yield of 2.93%.
| Dividend Per Share | 0.06 |
| Dividend Yield | 2.93% |
| Dividend Growth (YoY) | 2.42% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 115.69% |
| Buyback Yield | -4.49% |
| Shareholder Yield | -1.56% |
| Earnings Yield | 2.28% |
| FCF Yield | 21.66% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Dr. Martens has an Altman Z-Score of 4.97 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.97 |
| Piotroski F-Score | 6 |